Sweden · Delayed Price · Currency is SEK Nimbus Group AB (Publ) Earnings Call Transcripts
Fiscal Year 2026
-
Q1 saw a 14% sales decline, mainly from North America, with gross profit and EBITDA both down year-over-year. Operating cash flow improved significantly, and management is focused on inventory reduction, cost control, and revitalizing underperforming segments.
Fiscal Year 2025
-
Q4 2025 saw lower sales and increased losses, mainly due to weak North America demand, while Europe remained stable. Cost-saving measures, restructuring, and new product launches are underway, with a focus on improving efficiency and targeting growth in governmental sectors.
-
Q3 saw a sharp sales and profit decline, mainly due to North America, but cost controls and restructuring are showing early effects. Europe and the Nordics are stabilizing, and new commercial actions and product launches aim to revive U.S. momentum.
-
Q2 sales and EBITDA declined year-over-year, but order intake improved, especially in North America and Europe. Cost reductions and inventory management are yielding results, and management expects revenue and margins to improve from Q3 onward.
-
Q1 2025 saw a 13% sales decline to SEK 300 million and a negative EBITDA of SEK 13 million, with market uncertainty driven by tariffs and weak demand. Rights issue raised SEK 345 million, and retail sales grew 15% while commercial sales dropped. Inventory remains high, especially in Nordics and U.S.
Fiscal Year 2024
-
Premium product launches and a SEK 400 million defense order drove a 53% Q4 order intake increase, despite a 24% sales decline and SEK -60 million EBITA for 2024. Cost reductions, a successful rights issue, and market recovery in the Nordics position the company for improved performance.
-
Q3 sales fell 20% year-over-year to SEK 378 million, with EBITDA impacted by restructuring and lower volumes. Despite a 61% drop in European sales, order intake rose 18% year-over-year, and a major FMV order signals future growth.
-
Q2 sales declined 18% year-over-year to SEK 623 million, with EBITDA margin dropping to 7.2%. North America outperformed a weak European market, and production at EdgeWater and Finland resumed. Inventory and liquidity remain healthy, with positive outlook for H2.